Could Blood Flow Reveal Glaucoma Earlier? - Scorecard - MDSpire

Could Blood Flow Reveal Glaucoma Earlier?

  • By

  • Jim Gallagher, senior managing editor

  • March 1, 2026

  • 5 min

Share

Clinical Scorecard: Could Blood Flow Reveal Glaucoma Earlier?

At a Glance

CategoryDetail
ConditionPrimary open-angle glaucoma (POAG) and preperimetric glaucoma
Key MechanismsImpaired retinal blood flow autoregulation and vascular reactivity at the optic nerve head precede structural damage and vision loss
Target PopulationAdults in mid-60s with early or suspected glaucoma
Care SettingOphthalmology clinics and glaucoma specialty care

Key Highlights

  • Retinal blood flow autoregulation assessed via laser speckle contrast imaging differentiates early glaucoma from controls.
  • Hyperoxia-induced vascular reactivity is reduced in mild POAG, indicating impaired autoregulation.
  • Altered autoregulation may serve as an early biomarker before detectable structural or functional damage.

Guideline-Based Recommendations

Diagnosis

  • Consider dynamic assessment of retinal blood flow autoregulation as a supplementary diagnostic tool alongside OCT and perimetry.
  • Verify glaucoma diagnosis with specialist evaluation and incorporate vascular reactivity measures where available.

Management

  • Continue intraocular pressure (IOP) control but recognize that IOP monitoring alone may not capture all progression risk.
  • Explore interventions targeting ocular blood flow and vascular health as adjunctive strategies.

Monitoring & Follow-up

  • Monitor retinal blood flow autoregulation changes over time to detect early disease progression.
  • Use vascular reactivity indices such as resistivity index and volumetric skew as dynamic parameters.

Risks

  • Patients may progress despite well-controlled IOP due to impaired vascular autoregulation.
  • Systemic hemodynamic factors contribute to glaucoma risk and should be considered.

Patient & Prescribing Data

Patients with early or suspected primary open-angle glaucoma

Traditional IOP-lowering treatments may not fully prevent progression; vascular autoregulation assessment could guide earlier intervention.

Clinical Best Practices

  • Incorporate retinal blood flow autoregulation testing in early glaucoma evaluation when feasible.
  • Recognize vascular dysregulation as a pathophysiological feature contributing to glaucoma progression.
  • Use hyperoxia challenge tests to assess vascular reactivity as a potential early biomarker.
  • Maintain comprehensive glaucoma care including IOP control and vascular health monitoring.

References

Original Source(s)

Related Content